Doctors track new epilepsy Drug's Real-Life impact
NCT ID NCT05867160
Summary
This study aims to see how well an add-on anti-seizure medication works for adults with focal epilepsy in real-world settings. It will follow 300 patients for 12 months to measure changes in seizure frequency, safety, and quality of life. The goal is to understand the drug's effectiveness when used alongside other treatments in everyday medical care.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EPILEPSY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fondazione IRCCS Istituto Neurologico "Carlo Besta" U.O. Epilettologia Clinica e Sperimentale - Centro di Medicina del Sonno
Milan, 20133, Italy
Conditions
Explore the condition pages connected to this study.